Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
31
|
pubmed:dateCreated |
1993-9-16
|
pubmed:abstractText |
The human immunodeficiency virus type 1 (HIV-1) protease is a potential target of acquired immune deficiency syndrome (AIDS) therapy. A highly potent, perfectly symmetrical phosphinate inhibitor of this enzyme, SB204144, has been synthesized. It is a competitive inhibitor of HIV-1 protease, with an apparent inhibition constant of 2.8 nM at pH 6.0. The three-dimensional structure of SB204144 bound to the enzyme has been determined at 2.3-A resolution by X-ray diffraction techniques and refined to a crystallographic discrepancy factor, R (= sigma parallel F(o) magnitude to - Fc parallel/sigma magnitude of F(o)), of 0.178. The inhibitor is held in the enzyme active site by a set of hydrophobic and hydrophilic interactions, including an interaction between Arg8 and the center of the terminal benzene rings of the inhibitor. The phosphinate establishes a novel interaction with the two catalytic aspartates; each oxygen of the central phosphinic acid moiety interacts with a single oxygen of one aspartic acid, establishing a very short (2.2-2.4 A) oxygen-oxygen contact. As with the structures of penicillopepsin bound to phosphinate and phosphonate inhibitors [Fraser, M. E., Strynadka, N. C., Bartlett, P. A., Hanson, J. E., & James, M. N. (1992) Biochemistry 31, 5201-14], we interpret this short distance and the stereochemical environment of each pair of oxygens in terms of a hydrogen bond that has a symmetric single-well potential energy curve with the proton located midway between the two atoms.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/A 74704,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphinic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Sugar Alcohols,
http://linkedlifedata.com/resource/pubmed/chemical/Valine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
7972-80
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8347601-Amino Acid Sequence,
pubmed-meshheading:8347601-Binding Sites,
pubmed-meshheading:8347601-Catalysis,
pubmed-meshheading:8347601-Crystallization,
pubmed-meshheading:8347601-HIV Protease,
pubmed-meshheading:8347601-HIV Protease Inhibitors,
pubmed-meshheading:8347601-HIV-1,
pubmed-meshheading:8347601-Models, Molecular,
pubmed-meshheading:8347601-Molecular Conformation,
pubmed-meshheading:8347601-Molecular Sequence Data,
pubmed-meshheading:8347601-Organophosphorus Compounds,
pubmed-meshheading:8347601-Phosphinic Acids,
pubmed-meshheading:8347601-Protein Binding,
pubmed-meshheading:8347601-Recombinant Proteins,
pubmed-meshheading:8347601-Sugar Alcohols,
pubmed-meshheading:8347601-Valine,
pubmed-meshheading:8347601-X-Ray Diffraction
|
pubmed:year |
1993
|
pubmed:articleTitle |
Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis.
|
pubmed:affiliation |
Department of Macromolecular Sciences, SmithKline Beecham, King of Prussia, Pennsylvania 19406.
|
pubmed:publicationType |
Journal Article
|